Increased registration of hypertension and cancer diagnoses after the introduction of a new reimbursement system

被引:10
|
作者
Hjerpe, Per [1 ,2 ]
Bostrom, Kristina Bengtsson [1 ]
Lindblad, Ulf [3 ]
Merlo, Juan [2 ]
机构
[1] Skaraborg Primary Care, R&D Ctr, Skovde, Sweden
[2] Lund Univ, Dept Clin Sci Malmo, Fac Med, S-22100 Lund, Sweden
[3] Gothenburg Univ, Dept Publ Hlth & Community Med Primary Hlth Care, Sahlgrenska Acad, S-41124 Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
Electronic health records; general practice; ICD codes; incentive; multilevel analysis; primary health care; reimbursement; Sweden; BRIEF CONCEPTUAL TUTORIAL; SWEDISH PRIMARY-CARE; MULTILEVEL ANALYSIS; SOCIAL EPIDEMIOLOGY; HEALTH; SWEDEN;
D O I
10.3109/02813432.2012.735552
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective. To investigate the impact on ICD coding behaviour of a new case-mix reimbursement system based on coded patient diagnoses. The main hypothesis was that after the introduction of the new system the coding of chronic diseases like hypertension and cancer would increase and the variance in propensity for coding would decrease on both physician and health care centre (HCC) levels. Design. Cross-sectional multilevel logistic regression analyses were performed in periods covering the time before and after the introduction of the new reimbursement system. Setting. Skaraborg primary care, Sweden. Subjects. All patients (n = 76 546 to 79 826) 50 years of age and older visiting 468 to 627 physicians at the 22 public HCCs in five consecutive time periods of one year each. Main outcome measures. Registered codes for hypertension and cancer diseases in Skaraborg primary care database (SPCD). Results. After the introduction of the new reimbursement system the adjusted prevalence of hypertension and cancer in SPCD increased from 17.4% to 32.2% and from 0.79% to 2.32%, respectively, probably partly due to an increased diagnosis coding of indirect patient contacts. The total variance in the propensity for coding declined simultaneously at the physician level for both diagnosis groups. Conclusions. Changes in the healthcare reimbursement system may directly influence the contents of a research database that retrieves data from clinical practice. This should be taken into account when using such a database for research purposes, and the data should be validated for each diagnosis.
引用
收藏
页码:222 / 228
页数:7
相关论文
共 50 条
  • [1] Quality assurance in obstetrics after introduction of new reimbursement system
    Sens, B
    Rauskolb, R
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1997, 57 (07) : M123 - M127
  • [2] Cancer registration system: an introduction
    Sobue, Tomotaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (02) : 89 - 89
  • [3] Cancer registration system: an introduction
    Tomotaka Sobue
    International Journal of Clinical Oncology, 2015, 20 : 3 - 4
  • [4] Cancer registration system: an introduction
    Sobue, Tomotaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (01) : 3 - 4
  • [5] Cancer registration system: an introduction
    Tomotaka Sobue
    International Journal of Clinical Oncology, 2008, 13 : 89 - 89
  • [6] INCREASED COMORBIDITY DIAGNOSES AND HOSPITAL REIMBURSEMENT FROM COMPUTERIZED PREANESTHETIC EVALUATION SYSTEM
    GIBBY, GL
    PAULUS, DA
    SIROTA, DJ
    TRELOAR, RW
    JACKSON, KI
    GRAVENSTEIN, JS
    VANDERAA, JJ
    ANESTHESIOLOGY, 1994, 81 (3A) : A1229 - A1229
  • [7] Pulmonary hypertension is associated with an increased incidence of cancer diagnoses
    Roderburg, Christoph
    Loosen, Sven H.
    Hippe, Hans-Joerg
    Luedde, Tom
    Kostev, Karel
    Luedde, Mark
    PULMONARY CIRCULATION, 2022, 12 (02)
  • [8] FACTORS INFLUENCING REIMBURSEMENT PRICE OF NEW DRUGS AFTER INTRODUCTION OF POSITIVE LIST SYSTEM
    Park, S. E.
    Yim, E. Y.
    Lim, S. H.
    Bae, S. Y.
    Lee, E. K.
    Kim, K. H.
    You, M. Y.
    Lee, B., I
    VALUE IN HEALTH, 2012, 15 (04) : A24 - A24
  • [9] THE ANALYSIS OF NEW DRUG REIMBURSEMENT DECISION MAKING IN SOUTH KOREA AFTER THE INTRODUCTION OF POSITIVE LISTING SYSTEM
    Kim, S.
    Cho, H.
    Yoo, H.
    Cho, J.
    Kang, K.
    Kim, J.
    VALUE IN HEALTH, 2017, 20 (09) : A676 - A676
  • [10] ACCESS TO NEW DRUGS AFTER THE INTRODUCTION OF THE 2011 REIMBURSEMENT ACT IN POLAND
    Zaremba, A.
    Iwanczuk, T.
    Tatara, T.
    Misiak, J.
    Krakowian, P.
    Wysoczanski, W.
    VALUE IN HEALTH, 2016, 19 (07) : A467 - A467